Supplemental Disclosures (Tables)

3 Months Ended

Mar. 31, 2023

Payables And Accruals [Abstract]

Schedule of Other Current Assets

Other Current Assets

Other current assets consisted of the following (in thousands):

	March 31, 2023		December 31, 2022
Net cost reimbursement due from collaborators	$	18,362	$	6,294
Accrued interest on investments		2,004		2,210
License revenue contract assets		2,000		—
Other		637		848
	$	23,003	$	9,352

Schedules of Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	March 31, 2023		December 31, 2022
Accrued external research and development expenses	$	11,261	$	9,216
Accrued personnel costs		8,678		18,071
Accrued sublicense fees and royalties		7,281		15,768
Accrued external general and administrative expenses		2,577		2,187
Accrued purchases of property and equipment		913		806
Other accrued expenses and current liabilities		999		746
	$	31,709	$	46,794